tiprankstipranks
Trending News
More News >
Brainstorm Cell Therapeutics (BCLI)
NASDAQ:BCLI
US Market

Brainstorm Cell Therapeutics (BCLI) Ownership - Who Owns Brainstorm Cell Therapeutics?

Compare
560 Followers

Brainstorm Cell Therapeutics (BCLI) Ownership Overview

10.93%1.77%14.45%0.37%72.48%
10.93% Insiders
14.45% Other Institutional Investors
0.37% ETFs
72.48% Public Companies and Individual Investors
The ownership structure of Brainstorm Cell Therapeutics (BCLI) stock is a mix of institutional, retail, and individual investors. Approximately 16.59% of the company’s stock is owned by Institutional Investors, 10.93% is owned by Insiders, and 72.48% is owned by Public Companies and Individual Investors.
The ownership structure of Brainstorm Cell Therapeutics (BCLI) stock is a mix of institutional, retail, and individual investors. Approximately 16.22% of the company’s stock is owned by Institutional Investors, 10.93% is owned by Insiders, and 0.37% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Oct 02, 2024
xxxxxxxxxxxxx
$11119
Jul 24, 2024
xxxxxxxxxxxxx
$22050

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
334,349Insider4.61%387,845
79,515Insider1.10%92,237
77,451Institution1.07%89,843
68,464Insider0.94%79,418
52,000Insider0.72%60,320
48,229Insider0.66%55,946
47,541Institution0.66%55,148
44,349Insider0.61%51,445
43,777Insider0.60%50,781
41,054Insider0.57%47,623

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
77,451Institution1.07%89,843
47,541Institution0.66%55,148
3,152Institution0.04%3,656

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
26,734Institution0.37%34,754

FAQ

Who Owns Brainstorm Cell Therapeutics (BCLI)?
According to the latest TipRanks data, approximately 14.45% of the company's stock is held by institutional investors, 10.93% is held by insiders, and 72.48% is held by retail investors.
    What percentage of Brainstorm Cell Therapeutics (BCLI) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 14.45% of Brainstorm Cell Therapeutics (BCLI) stock is held by institutional investors.
      What percentage of Brainstorm Cell Therapeutics (BCLI) stock is held by retail investors?
      According to the latest TipRanks data, approximately 72.48% of Brainstorm Cell Therapeutics (BCLI) stock is held by retail investors.
        Who owns the most shares of Brainstorm Cell Therapeutics (BCLI)?
        Chaim Lebovits owns the most shares of Brainstorm Cell Therapeutics (BCLI).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis